Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB680 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	SENATE FLOOR VERSION - SB680 SFLR Page 1
4		-	(Bold face denotes Committee Amendments) 1
	3	+
	4	+	Req. No. 1472 Page 1 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
	28	+	1
5	29		2
6	30		3
7	31		4
8	32		5
9	33		6
10	34		7
11	35		8
12	36		9
13	37		10
14	38		11
15	39		12
16	40		13
17	41		14
18	42		15
19	43		16
20	44		17
21	45		18
22	46		19
23	47		20
24	48		21
25	49		22
26	50		23
27	51		24
28	52
	53	+	STATE OF OKLAHOMA
29	54
30		-	SENATE FLOOR VERSION
31		-	February 22, 2021
	55	+	1st Session of the 58th Legislature (2021)
32	56
33		-
34		-	SENATE BILL NO. 680 By: Daniels
	57	+	SENATE BILL 680 By: Daniels
35	58
36	59
37	60
38	61
39	62
	63	+	AS INTRODUCED
40	64
41	65		An Act relating to medical marijuana; amending
42	66		Section 2, Chapter 11, O.S.L. 2019, as last amended
43	67		by Section 48, Chapter 161, O.S.L. 20 20 (63 O.S.
44	68		Supp. 2020, Section 427.2) , which relates to
45	69		definitions used in the Oklahoma Medical Marijuana
46	70		and Patient Protection Act ; modifying definition;
47	71		amending Section 17, Chapter 11, O.S.L. 2019, as
48	72		amended by Section 4, Chapter 312, O.S.L. 2 019 (63
49	73		O.S. Supp. 2020, Section 427.17) , which relates to
50	74		medical marijuana testing laboratory license ;
51	75		requiring testing of med ical marijuana waste prior to
52	76		transfer; requiring separation of medical marijuana
53	77		waste into waste batches; modifying provisions to
54	78		include medical marijuana waste; clarifying language;
55	79		updating statutory references; and providing an
56	80		effective date.
57	81
58	82
59	83
60	84
	85	+
	86	+
61	87		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
62	88		SECTION 1. AMENDATORY Section 2, Chapter 11, O.S.L.
63	89		2019, as last amended by Section 48, Chapter 161, O.S.L. 2020 (63
64	90		O.S. Supp. 2020, Section 427.2), is amended to read as follows:
65	91		Section 427.2. As used in this act the Oklahoma Medical
66	92		Marijuana and Patient Protection Act :
67		-	1. “Advertising” means the act of providing consideratio n for
68		-	the publication, dissemination, solicitation, or circulation, of
69	93
70		-	SENATE FLOOR VERSION - SB680 SFLR Page 2
71		-	(Bold face denotes Committee Amendments) 1
	94	+
	95	+	Req. No. 1472 Page 2 1
	96	+	2
	97	+	3
	98	+	4
	99	+	5
	100	+	6
	101	+	7
	102	+	8
	103	+	9
	104	+	10
	105	+	11
	106	+	12
	107	+	13
	108	+	14
	109	+	15
	110	+	16
	111	+	17
	112	+	18
	113	+	19
	114	+	20
	115	+	21
	116	+	22
	117	+	23
	118	+	24
	119	+	1
72	120		2
73	121		3
74	122		4
75	123		5
76	124		6
77	125		7
78	126		8
79	127		9
80	128		10
81	129		11
82	130		12
83	131		13
84	132		14
85	133		15
86	134		16
87	135		17
88	136		18
89	137		19
90	138		20
91	139		21
92	140		22
93	141		23
94	142		24
95	143
	144	+	1. “Advertising” means the act of providing consideration for
	145	+	the publication, dissemination, solicitation, or circulation, of
96	146		visual, oral, or written communication to induce directly or
97	147		indirectly any person to patronize a par ticular medical marijuana
98	148		business, or to purchase particular medical marijuana or a medic al
99	149		marijuana product. Advertising includes marketing, but does not
100	150		include packaging and labeling;
101	151		2. “Authority” means the Oklahoma Medi cal Marijuana Authority;
102	152		3. “Batch number” means a unique numeric or alphanu meric
103	153		identifier assigned prior to testi ng to allow for inventory tracking
104	154		and traceability;
105	155		4. “Cannabinoid” means any of the chemical compounds that are
106	156		active principles of ma rijuana;
107	157		5. “Caregiver” means a family member or assis tant who regularly
108	158		looks after a medical marijuana license hol der whom a physician
109	159		attests needs assistance;
110	160		6. “Child-resistant” means special packaging that is:
111	161		a. designed or constructed to be sign ificantly difficult
112	162		for children under five (5) years o f age to open and
113	163		not difficult for normal adults to use prope rly as
114	164		defined by 16 C.F.R. 1700.15 (1995) and 16 C.F.R.
115	165		1700.20 (1995),
116		-	b. opaque so that the outermost packaging does not allow
117		-	the product to be seen without openi ng the packaging
118		-	material, and
119	166
120		-	SENATE FLOOR VERSION - SB680 SFLR Page 3
121		-	(Bold face denotes Committee Amendments) 1
	167	+
	168	+	Req. No. 1472 Page 3 1
	169	+	2
	170	+	3
	171	+	4
	172	+	5
	173	+	6
	174	+	7
	175	+	8
	176	+	9
	177	+	10
	178	+	11
	179	+	12
	180	+	13
	181	+	14
	182	+	15
	183	+	16
	184	+	17
	185	+	18
	186	+	19
	187	+	20
	188	+	21
	189	+	22
	190	+	23
	191	+	24
	192	+	1
122	193		2
123	194		3
124	195		4
125	196		5
126	197		6
127	198		7
128	199		8
129	200		9
130	201		10
131	202		11
132	203		12
133	204		13
134	205		14
135	206		15
136	207		16
137	208		17
138	209		18
139	210		19
140	211		20
141	212		21
142	213		22
143	214		23
144	215		24
145	216
	217	+	b. opaque so that the outermost packaging does not allow
	218	+	the product to be seen without openi ng the packaging
	219	+	material, and
146	220		c. resealable to maintain its child-resistant
147	221		effectiveness for multiple openings for any product
148	222		intended for more than a single use or containing
149	223		multiple servings;
150	224		7. “Clone” means a nonflowering plant cut from a mother plant
151	225		that is capable of deve loping into a new plan t and has shown no
152	226		signs of flowering;
153	227		8. “Commissioner” means the State Commissioner of Health;
154	228		9. “Complete application ” means a document prepared in
155	229		accordance with the provi sions set forth in this act the Oklahoma
156	230		Medical Marijuana and Patient Protect ion Act, rules promulgated
157	231		pursuant thereto, and the form s and instructions provided by the
158	232		Department, including any supporting documentation required and the
159	233		applicable license application fee;
160	234		10. “Department” means the State Depart ment of Health;
161	235		11. “Director” means the Executive Dir ector of the Oklahoma
162	236		Medical Marijuana Authority;
163	237		12. “Dispense” means the selling of medical marijuana or a
164	238		medical marijuana product to a qualified patient or the des ignated
165	239		caregiver of the patien t that is packaged in a suitable container
166		-	appropriately labeled for subsequent administration to or use by a
167		-	qualifying patient;
168		-	13. “Dispensary” means a medical marijuana dispensary, an
169		-	entity that has been licensed by the Department pursuant to this act
170	240
171		-	SENATE FLOOR VERSION - SB680 SFLR Page 4
172		-	(Bold face denotes Committee Amendments) 1
	241	+
	242	+	Req. No. 1472 Page 4 1
	243	+	2
	244	+	3
	245	+	4
	246	+	5
	247	+	6
	248	+	7
	249	+	8
	250	+	9
	251	+	10
	252	+	11
	253	+	12
	254	+	13
	255	+	14
	256	+	15
	257	+	16
	258	+	17
	259	+	18
	260	+	19
	261	+	20
	262	+	21
	263	+	22
	264	+	23
	265	+	24
	266	+	1
173	267		2
174	268		3
175	269		4
176	270		5
177	271		6
178	272		7
179	273		8
180	274		9
181	275		10
182	276		11
183	277		12
184	278		13
185	279		14
186	280		15
187	281		16
188	282		17
189	283		18
190	284		19
191	285		20
192	286		21
193	287		22
194	288		23
195	289		24
196	290
	291	+	appropriately labeled for subseque nt administration to or use by a
	292	+	qualifying patient;
	293	+	13. “Dispensary” means a medical marijuana dispensary, an
	294	+	entity that has been licensed by the Department pursuant to this act
197	295		the Oklahoma Medical Marijuana and Patient Protection Act to
198	296		purchase medical marijuana or medical marijuana pr oducts from a
199	297		licensed medical marijuana commercial grower or medical marijuana
200	298		processor, sell medical marijuan a or medical marijuana products to
201	299		patients and caregivers as defined under this act Section 427.1 et
202	300		seq. of this title, or sell or transfer products to another
203	301		dispensary;
204	302		14. “Edible medical marijua na product” means any medical-
205	303		marijuana-infused product for which the intended use is oral
206	304		consumption including, but not limited to, any type of food, drink
207	305		or pill;
208	306		15. “Entity” means an individual, general partnership, limited
209	307		partnership, limited liab ility company, trust, estate, associatio n,
210	308		corporation, cooperative, or any other legal or commercial ent ity;
211	309		16. “Flower” means the reproductive organs of the marijuana or
212	310		cannabis plant referred to as the bud or parts of the plant that are
213	311		harvested and used to consume in a variety of medical marijuana
214	312		products;
215		-	17. “Flowering” means the reproductive state of the marijuana
216		-	or cannabis plant in which there are physical signs of flower or
217		-	budding out of the nodes of the stem;
218		-	18. “Food-based medical marijuana concentrate” means a medical
219		-	marijuana concentrate that was produced by extracting cannabinoids
220		-	from medical marijuana through the u se of propylene glycol,
221	313
222		-	SENATE FLOOR VERSION - SB680 SFLR Page 5
223		-	(Bold face denotes Committee Amendments) 1
	314	+
	315	+	Req. No. 1472 Page 5 1
	316	+	2
	317	+	3
	318	+	4
	319	+	5
	320	+	6
	321	+	7
	322	+	8
	323	+	9
	324	+	10
	325	+	11
	326	+	12
	327	+	13
	328	+	14
	329	+	15
	330	+	16
	331	+	17
	332	+	18
	333	+	19
	334	+	20
	335	+	21
	336	+	22
	337	+	23
	338	+	24
	339	+	1
224	340		2
225	341		3
226	342		4
227	343		5
228	344		6
229	345		7
230	346		8
231	347		9
232	348		10
233	349		11
234	350		12
235	351		13
236	352		14
237	353		15
238	354		16
239	355		17
240	356		18
241	357		19
242	358		20
243	359		21
244	360		22
245	361		23
246	362		24
247	363
	364	+	17. “Flowering” means the reproductive stat e of the marijuana
	365	+	or cannabis plant in which there are physical signs of flower or
	366	+	budding out of the nodes of the stem;
	367	+	18. “Food-based medical marijuana concentrate” means a medical
	368	+	marijuana concentrate that was produced by extracting cannabinoids
	369	+	from medical marijuana through the use of propylene glycol,
248	370		glycerin, butter, olive oil, coconut oil or other typical food -safe
249	371		cooking fats;
250	372		19. “Good cause” for purposes of an initial, renewa l or
251	373		reinstatement license application, or for purposes of discip line of
252	374		a licensee, means:
253	375		a. the licensee or applicant has violated, does not meet,
254	376		or has failed to comply with any of the term s,
255	377		conditions or provisions of the act, any rules
256	378		promulgated pursuant thereto, or any supplemental
257	379		relevant state or local law , rule or regulation,
258	380		b. the licensee or applicant has failed to comply wi th
259	381		any special terms or conditions that were placed upo n
260	382		the license pursuant to an order of the State
261	383		Department of Health, Oklahoma Medical Marijuana
262	384		Authority or the municipality, or
263	385		c. the licensed premises of a medical marijuana business
264	386		or applicant have been operated in a manner that
265	387		adversely affects the public health or we lfare or the
266		-	safety of the immediate vic inity in which the
267		-	establishment is located;
268		-	20. “Harvest batch” means a specifically identified quantity of
269		-	medical marijuana that is uni form in strain, cultivated utilizing
270		-	the same cultivation practices, harveste d at the same time from the
271		-	same location and cured under uniform conditions;
272	388
273		-	SENATE FLOOR VERSION - SB680 SFLR Page 6
274		-	(Bold face denotes Committee Amendments) 1
	389	+
	390	+	Req. No. 1472 Page 6 1
	391	+	2
	392	+	3
	393	+	4
	394	+	5
	395	+	6
	396	+	7
	397	+	8
	398	+	9
	399	+	10
	400	+	11
	401	+	12
	402	+	13
	403	+	14
	404	+	15
	405	+	16
	406	+	17
	407	+	18
	408	+	19
	409	+	20
	410	+	21
	411	+	22
	412	+	23
	413	+	24
	414	+	1
275	415		2
276	416		3
277	417		4
278	418		5
279	419		6
280	420		7
281	421		8
282	422		9
283	423		10
284	424		11
285	425		12
286	426		13
287	427		14
288	428		15
289	429		16
290	430		17
291	431		18
292	432		19
293	433		20
294	434		21
295	435		22
296	436		23
297	437		24
298	438
	439	+	safety of the immediate vic inity in which the
	440	+	establishment is located;
	441	+	20. “Harvest batch” means a specifically identified quantity of
	442	+	medical marijuana that is uni form in strain, cultivated utilizing
	443	+	the same cultivation practices, harveste d at the same time from the
	444	+	same location and cured under uniform conditions;
299	445		21. “Harvested marijuana” means post-flowering medical
300	446		marijuana not including trim, concentrate or waste;
301	447		22. “Heat- or pressure-based medical marijuana concentrate”
302	448		means a medical marijuana concentrate that was pr oduced by
303	449		extracting cannabinoids from medical marijuana through the use of
304	450		heat or pressure;
305	451		23. “Immature plant” means a nonflowering ma rijuana plant that
306	452		has not demonstrated signs of flower ing;
307	453		24. “Inventory tracking system” means the required track ing
308	454		system that accounts for medical marijuana from either the se ed or
309	455		immature plant stage until the medical marijuana or medical
310	456		marijuana product is sold to a patient at a medical marijuana
311	457		dispensary, transferred to a medical marijuana research facilit y,
312	458		destroyed by a medical marijuana business or used in a researc h
313	459		project by a medical marijuana research facility;
314	460		25. “Licensed patient” or “patient” means a person who has been
315	461		issued a medical marijuana patient license by the State Department
316	462		of Health or Oklahoma Medical Marijuana Authority;
317		-	26. “Licensed premises” means the premises specified in an
318		-	application for a medical marijuana business license, medical
319		-	marijuana research facility license or medical mar ijuana education
320		-	facility license pursua nt to this act the Oklahoma Medical Marijuana
321		-	and Patient Protection Act that are owned or in poss ession of the
322		-	licensee and within which the licensee is authorized to cultivate,
323	463
324		-	SENATE FLOOR VERSION - SB680 SFLR Page 7
325		-	(Bold face denotes Committee Amendments) 1
	464	+
	465	+	Req. No. 1472 Page 7 1
	466	+	2
	467	+	3
	468	+	4
	469	+	5
	470	+	6
	471	+	7
	472	+	8
	473	+	9
	474	+	10
	475	+	11
	476	+	12
	477	+	13
	478	+	14
	479	+	15
	480	+	16
	481	+	17
	482	+	18
	483	+	19
	484	+	20
	485	+	21
	486	+	22
	487	+	23
	488	+	24
	489	+	1
326	490		2
327	491		3
328	492		4
329	493		5
330	494		6
331	495		7
332	496		8
333	497		9
334	498		10
335	499		11
336	500		12
337	501		13
338	502		14
339	503		15
340	504		16
341	505		17
342	506		18
343	507		19
344	508		20
345	509		21
346	510		22
347	511		23
348	512		24
349	513
	514	+	26. “Licensed premises” means the premises specified in an
	515	+	application for a medical marijuana business license, medical
	516	+	marijuana research facility license or medical mar ijuana education
	517	+	facility license pursua nt to this act the Oklahoma Medical Marijuana
	518	+	and Patient Protection Act that are owned or in possession of the
	519	+	licensee and within which the licensee is authorized to cultivate,
350	520		manufacture, distribute, sell, store, transport, test or research
351	521		medical marijuana or medical marijuana products in accordance with
352	522		the provisions of this act the Oklahoma Medical Marijuana and
353	523		Patient Protection Act and rules promulgated pursuant thereto;
354	524		27. “Manufacture” means the production, propagation,
355	525		compounding or proce ssing of a medical marijuana product, excluding
356	526		marijuana plants, either directly or indirectly by extraction from
357	527		substances of natural or synthetic origin, or independently by means
358	528		of chemical synthesis, or by a combination of extraction and
359	529		chemical synthesis;
360	530		28. “Marijuana” shall have the same meaning a s such term is
361	531		defined in Section 2-101 of Title 63 of the Okl ahoma Statutes;
362	532		29. “Material change” means any change that would require a
363	533		substantive revision to the standard operating procedures of a
364	534		licensee for the cultivation or production of medical marijuana,
365	535		medical marijuana concentrate or medical marijuana products;
366	536		30. “Mature plant” means a harvestable female marijuana plant
367	537		that is flowering;
368		-	31. “Medical marijuana business (MMB) ” means a licensed medical
369		-	marijuana dispensary, medical marijua na processor, medical marijuana
370		-	commercial grower, medical marijuana laboratory, medical marijuana
371		-	business operator, or a medical marijuana transporter;
372		-	32. “Medical marijuana concentrate ” or “concentrate” means a
373		-	specific subset of medical marijuana tha t was produced by extracting
374	538
375		-	SENATE FLOOR VERSION - SB680 SFLR Page 8
376		-	(Bold face denotes Committee Amendments) 1
	539	+
	540	+	Req. No. 1472 Page 8 1
	541	+	2
	542	+	3
	543	+	4
	544	+	5
	545	+	6
	546	+	7
	547	+	8
	548	+	9
	549	+	10
	550	+	11
	551	+	12
	552	+	13
	553	+	14
	554	+	15
	555	+	16
	556	+	17
	557	+	18
	558	+	19
	559	+	20
	560	+	21
	561	+	22
	562	+	23
	563	+	24
	564	+	1
377	565		2
378	566		3
379	567		4
380	568		5
381	569		6
382	570		7
383	571		8
384	572		9
385	573		10
386	574		11
387	575		12
388	576		13
389	577		14
390	578		15
391	579		16
392	580		17
393	581		18
394	582		19
395	583		20
396	584		21
397	585		22
398	586		23
399	587		24
400	588
	589	+	31. “Medical marijuana business (MMB) ” means a licensed medical
	590	+	marijuana dispensary, medical marijua na processor, medical marijuana
	591	+	commercial grower, medical mar ijuana laboratory, medical marijuana
	592	+	business operator, or a medical marijuana transporter;
	593	+	32. “Medical marijuana concentrate ” or “concentrate” means a
	594	+	specific subset of medical marijuana tha t was produced by extracting
401	595		cannabinoids from medical marijua na. Categories of medical
402	596		marijuana concentrate include water -based medical marijuana
403	597		concentrate, food-based medical marijuana concentrat e, solvent-based
404	598		medical marijuana concentrate, and hea t- or pressure-based medical
405	599		marijuana concentrate;
406	600		33. “Medical marijuana commercial grower ” or “commercial
407	601		grower” means an entity licensed to cultivate, prepare and package
408	602		medical marijuana and tr ansfer or contract for transfer medical
409	603		marijuana to a medical marijuana dispensary, medical marijuana
410	604		processor, any other medical marijuana commercial grower, medical
411	605		marijuana research facility, medical marijuana education facility
412	606		and pesticide manufac turers. A commercial grower may sell seeds,
413	607		flower or clones to commercial growers pursuant to this act the
414	608		Oklahoma Medical Marijuana and Patient Protection Act ;
415	609		34. “Medical marijuana education facility ” or “education
416	610		facility” means a person or entity approved pursu ant to this act the
417	611		Oklahoma Medical Marijuana and Patient Protection Act to operate a
418	612		facility providing training and education to individuals involving
419		-	the cultivation, growing , harvesting, curing, preparing, packagi ng
420		-	or testing of medical marijuana, or the production, manufacture,
421		-	extraction, processing, packaging or creation of medic al-marijuana-
422		-	infused products or medical marijuana products as described in this
423		-	act the Oklahoma Medical Marijuana and Patient Protection Act ;
424	613
425		-	SENATE FLOOR VERSION - SB680 SFLR Page 9
426		-	(Bold face denotes Committee Amendments) 1
	614	+
	615	+	Req. No. 1472 Page 9 1
	616	+	2
	617	+	3
	618	+	4
	619	+	5
	620	+	6
	621	+	7
	622	+	8
	623	+	9
	624	+	10
	625	+	11
	626	+	12
	627	+	13
	628	+	14
	629	+	15
	630	+	16
	631	+	17
	632	+	18
	633	+	19
	634	+	20
	635	+	21
	636	+	22
	637	+	23
	638	+	24
	639	+	1
427	640		2
428	641		3
429	642		4
430	643		5
431	644		6
432	645		7
433	646		8
434	647		9
435	648		10
436	649		11
437	650		12
438	651		13
439	652		14
440	653		15
441	654		16
442	655		17
443	656		18
444	657		19
445	658		20
446	659		21
447	660		22
448	661		23
449	662		24
450	663
	664	+	the cultivation, growing , harvesting, curing, preparing, packagi ng
	665	+	or testing of medical marijuana, or the production, manufacture,
	666	+	extraction, processin g, packaging or creation of medical -marijuana-
	667	+	infused products or medical marijuana products as described in this
	668	+	act the Oklahoma Medical Marijuana and Patient Protection Act ;
451	669		35. “Medical-marijuana-infused product” means a product infused
452	670		with medical marijuana including, but not limited to, edible
453	671		products, ointments and tinctures;
454	672		36. “Medical marijuana pr oduct” or “product” means a product
455	673		that contains cannabinoids that have been extracted from plant
456	674		material or the resin therefrom by physical or ch emical means and is
457	675		intended for administration to a qualified patient including, but
458	676		not limited to, oils, tinctures, edibles, pills, topical forms,
459	677		gels, creams, vapors, patches, liqu ids, and forms admin istered by a
460	678		nebulizer, excluding live plant forms which are considered medical
461	679		marijuana;
462	680		37. “Medical marijuana processor ” means a person or entity
463	681		licensed pursuant to this act the Oklahoma Medical Marijuana and
464	682		Patient Protection Act to operate a business including the
465	683		production, manufacture, extraction, processing, packaging or
466	684		creation of concentrate, medical -marijuana-infused products or
467	685		medical marijuana products as described in this act the Oklahoma
468	686		Medical Marijuana and Patient Protection Act ;
469		-	38. “Medical marijuana research facility” or “research
470		-	facility” means a person or entity approved pursuant to this act the
471		-	Oklahoma Medical Marijuana and Patient Protection Act to conduct
472		-	medical marijuana research. A medical marijuana research facility
473		-	is not a medical marijuana business;
474	687
475		-	SENATE FLOOR VERSION - SB680 SFLR Page 10
476		-	(Bold face denotes Committee Amendments) 1
	688	+
	689	+	Req. No. 1472 Page 10 1
	690	+	2
	691	+	3
	692	+	4
	693	+	5
	694	+	6
	695	+	7
	696	+	8
	697	+	9
	698	+	10
	699	+	11
	700	+	12
	701	+	13
	702	+	14
	703	+	15
	704	+	16
	705	+	17
	706	+	18
	707	+	19
	708	+	20
	709	+	21
	710	+	22
	711	+	23
	712	+	24
	713	+	1
477	714		2
478	715		3
479	716		4
480	717		5
481	718		6
482	719		7
483	720		8
484	721		9
485	722		10
486	723		11
487	724		12
488	725		13
489	726		14
490	727		15
491	728		16
492	729		17
493	730		18
494	731		19
495	732		20
496	733		21
497	734		22
498	735		23
499	736		24
500	737
	738	+	38. “Medical marijuana research facility” or “research
	739	+	facility” means a person or entity approv ed pursuant to this act the
	740	+	Oklahoma Medical Marijuana and Patient Protection Act to conduct
	741	+	medical marijuana research. A medical marijuana research facility
	742	+	is not a medical marijuana business;
501	743		39. “Medical marijuana testing laborato ry” or “laboratory”
502	744		means a public or private laborator y licensed pursuant to this act,
503	745		the Oklahoma Medical Marijuana and Patient Protection Act to conduct
504	746		testing and research on medical marijuana and, medical marijuana
505	747		products and medical marijuana waste ;
506	748		40. “Medical marijuana transporter ” or “transporter” means a
507	749		person or entity that is lic ensed pursuant to this act the Oklahoma
508	750		Medical Marijuana and Patient Protection Act . A medical marijuana
509	751		transporter does not include a medical marijuana business that
510	752		transports its own medical marijuana, medical marijuana concentrate
511	753		or medical marijuana products to a property or facility adjacent to
512	754		or connected to the licensed premises if the property is another
513	755		licensed premises of the same medical marijuana business;
514	756		41. “Medical marijuana waste ” or “waste” means unused, surplus,
515	757		returned or out-of-date marijuana, plant debris of the plant of the
516	758		genus Cannabis, including dead plants and all unused plant parts and
517	759		roots, except the term shall not include roots, stems, stalks and
518	760		fan leaves;
519		-	42. “Medical use” means the acquisition, possession, use,
520		-	delivery, transfer or transportation of medical marijuana, medical
521		-	marijuana products, medical marijuana devices or paraphernalia
522		-	relating to the administration of medic al marijuana to treat a
523		-	licensed patient;
524	761
525		-	SENATE FLOOR VERSION - SB680 SFLR Page 11
526		-	(Bold face denotes Committee Amendments) 1
	762	+
	763	+	Req. No. 1472 Page 11 1
	764	+	2
	765	+	3
	766	+	4
	767	+	5
	768	+	6
	769	+	7
	770	+	8
	771	+	9
	772	+	10
	773	+	11
	774	+	12
	775	+	13
	776	+	14
	777	+	15
	778	+	16
	779	+	17
	780	+	18
	781	+	19
	782	+	20
	783	+	21
	784	+	22
	785	+	23
	786	+	24
	787	+	1
527	788		2
528	789		3
529	790		4
530	791		5
531	792		6
532	793		7
533	794		8
534	795		9
535	796		10
536	797		11
537	798		12
538	799		13
539	800		14
540	801		15
541	802		16
542	803		17
543	804		18
544	805		19
545	806		20
546	807		21
547	808		22
548	809		23
549	810		24
550	811
	812	+	42. “Medical use” means the acquisition, possession, use,
	813	+	delivery, transfer or transportation of medical marijuana, medical
	814	+	marijuana products, medical marijuana devices or paraphernalia
	815	+	relating to the administration of medical marijuana to treat a
	816	+	licensed patient;
551	817		43. “Mother plant” means a marijuana plant that is grown or
552	818		maintained for the purpose of generating c lones, and that will not
553	819		be used to produce plant material for sale to a medic al marijuana
554	820		processor or medical marijuana dispensary;
555	821		44. “Oklahoma physician” or “physician” means a physician
556	822		licensed by and in good standing with the State Board of Medica l
557	823		Licensure and Supervision, the State Board of Osteopathic Examiners
558	824		or the Board of Podiatric Medical Examiners;
559	825		45. “Oklahoma resident” means an individual who can provide
560	826		proof of residency as required by this act the Oklahoma Medical
561	827		Marijuana and Patient Protection Act ;
562	828		46. “Owner” means, except where the context otherwise requires,
563	829		a direct beneficial owner including, but not limited to, all persons
564	830		or entities as follows:
565	831		a. all shareholders owning an interest of a corporate
566	832		entity and all officers of a corporate entity,
567	833		b. all partners of a general part nership,
568	834		c. all general partners and all limited partners that own
569	835		an interest in a limited partnership,
570		-	d. all members that own an interest in a limited
571		-	liability company,
572		-	e. all beneficiaries that hold a beneficial interest in a
573		-	trust and all trustees of a trust,
574	836
575		-	SENATE FLOOR VERSION - SB680 SFLR Page 12
576		-	(Bold face denotes Committee Amendments) 1
	837	+
	838	+	Req. No. 1472 Page 12 1
	839	+	2
	840	+	3
	841	+	4
	842	+	5
	843	+	6
	844	+	7
	845	+	8
	846	+	9
	847	+	10
	848	+	11
	849	+	12
	850	+	13
	851	+	14
	852	+	15
	853	+	16
	854	+	17
	855	+	18
	856	+	19
	857	+	20
	858	+	21
	859	+	22
	860	+	23
	861	+	24
	862	+	1
577	863		2
578	864		3
579	865		4
580	866		5
581	867		6
582	868		7
583	869		8
584	870		9
585	871		10
586	872		11
587	873		12
588	874		13
589	875		14
590	876		15
591	877		16
592	878		17
593	879		18
594	880		19
595	881		20
596	882		21
597	883		22
598	884		23
599	885		24
600	886
	887	+	d. all members that own an interest in a limited
	888	+	liability company,
	889	+	e. all beneficiaries that hold a beneficial interest in a
	890	+	trust and all trustees of a trust,
601	891		f. all persons or entities that own interest in a joint
602	892		venture,
603	893		g. all persons or entities that own an interest in an
604	894		association,
605	895		h. the owners of any other type of legal entity, and
606	896		i. any other person holding an interest or convertible
607	897		note in any entity which owns, operates or mana ges a
608	898		licensed facility;
609	899		47. “Package” or “packaging” means any container or wrapper
610	900		that may be used by a medical marijuana business to enclose or
611	901		contain medical marijuana;
612	902		48. “Person” means a natural person, p artnership, association,
613	903		business trust, company, corporation, estate, limited li ability
614	904		company, trust or any other legal entity or organization, or a
615	905		manager, agent, owner, director, servant, officer or employee
616	906		thereof, except that “person” does not include any governmental
617	907		organization;
618	908		49. “Pesticide” means any substance or mixtu re of substances
619	909		intended for preventing, destroying, repelling or mitigating any
620	910		pest or any substance or mixture of substances intended for us e as a
621		-	plant regulator, defolia nt or desiccant, except that the term
622		-	“pesticide” shall not include any article that is a “new animal
623		-	drug” as designated by the United States Food and Drug
624		-	Administration;
625	911
626		-	SENATE FLOOR VERSION - SB680 SFLR Page 13
627		-	(Bold face denotes Committee Amendments) 1
	912	+
	913	+	Req. No. 1472 Page 13 1
	914	+	2
	915	+	3
	916	+	4
	917	+	5
	918	+	6
	919	+	7
	920	+	8
	921	+	9
	922	+	10
	923	+	11
	924	+	12
	925	+	13
	926	+	14
	927	+	15
	928	+	16
	929	+	17
	930	+	18
	931	+	19
	932	+	20
	933	+	21
	934	+	22
	935	+	23
	936	+	24
	937	+	1
628	938		2
629	939		3
630	940		4
631	941		5
632	942		6
633	943		7
634	944		8
635	945		9
636	946		10
637	947		11
638	948		12
639	949		13
640	950		14
641	951		15
642	952		16
643	953		17
644	954		18
645	955		19
646	956		20
647	957		21
648	958		22
649	959		23
650	960		24
651	961
	962	+	plant regulator, defolia nt or desiccant, except that the term
	963	+	“pesticide” shall not include any article t hat is a “new animal
	964	+	drug” as designated by the United States Food and Drug
	965	+	Administration;
652	966		50. “Production batch” means:
653	967		a. any amount of medical marijuana concentrate of th e
654	968		same category and produced using the sa me extraction
655	969		methods, standard operatin g procedures and an
656	970		identical group of harvest batch of medical marijuana,
657	971		or
658	972		b. any amount of medical marijuana product of the same
659	973		exact type, produced using the same ingred ients,
660	974		standard operating procedures and the same production
661	975		batch of medical mar ijuana concentrate;
662	976		51. “Public institution” means any entity established or
663	977		controlled by the federal government, state government, or a local
664	978		government or municipality inc luding, but not limited to,
665	979		institutions of higher education or related research institutions;
666	980		52. “Public money” means any funds or money obtained by the
667	981		holder from any governmental entity including, but not limited to,
668	982		research grants;
669	983		53. “Recommendation” means a document that is signed or
670	984		electronically submitted by a physician on behalf of a patient for
671		-	the use of medical marijuana pursuant to this act the Oklahoma
672		-	Medical Marijuana and Patient Protection Act ;
673		-	54. “Registered to conduct business ” means a person that has
674		-	provided proof that the busine ss applicant is in good standing with
675		-	the Oklahoma Secretary of State and Oklahoma Tax Commission;
676	985
677		-	SENATE FLOOR VERSION - SB680 SFLR Page 14
678		-	(Bold face denotes Committee Amendments) 1
	986	+
	987	+	Req. No. 1472 Page 14 1
	988	+	2
	989	+	3
	990	+	4
	991	+	5
	992	+	6
	993	+	7
	994	+	8
	995	+	9
	996	+	10
	997	+	11
	998	+	12
	999	+	13
	1000	+	14
	1001	+	15
	1002	+	16
	1003	+	17
	1004	+	18
	1005	+	19
	1006	+	20
	1007	+	21
	1008	+	22
	1009	+	23
	1010	+	24
	1011	+	1
679	1012		2
680	1013		3
681	1014		4
682	1015		5
683	1016		6
684	1017		7
685	1018		8
686	1019		9
687	1020		10
688	1021		11
689	1022		12
690	1023		13
691	1024		14
692	1025		15
693	1026		16
694	1027		17
695	1028		18
696	1029		19
697	1030		20
698	1031		21
699	1032		22
700	1033		23
701	1034		24
702	1035
	1036	+	the use of medical marijuana pursuant to this act the Oklahoma
	1037	+	Medical Marijuana and Patient Protection Act ;
	1038	+	54. “Registered to conduct business ” means a person that h as
	1039	+	provided proof that the business ap plicant is in good standing with
	1040	+	the Oklahoma Secretary of State and Oklahoma Tax Commission;
703	1041		55. “Remediation” means the process by which the medical
704	1042		marijuana flower or trim, which has failed microbial testing, is
705	1043		processed into solvent -based medical marijuana concentrate and
706	1044		retested as required by this act the Oklahoma Medical Marijuana and
707	1045		Patient Protection Act ;
708	1046		56. “Research project” means a discrete scientific endeavor to
709	1047		answer a research question or a set of research questions related to
710	1048		medical marijuana and is required for a medical marijuana researc h
711	1049		license. A research project shall incl ude a description of a
712	1050		defined protocol, clearly articulated goals, defined methods and
713	1051		outputs, and a defined start an d end date. The description shall
714	1052		demonstrate that the research project will comply with all
715	1053		requirements in this act the Oklahoma Medical Marijuana and Patient
716	1054		Protection Act and rules promulgated pursuant thereto. All research
717	1055		and development conducted by a medical marijuana research facility
718	1056		shall be conducted in furtherance of an approved research project;
719	1057		57. “Revocation” means the final decision by the Department
720	1058		that any license issued p ursuant to this act the Oklahoma Medical
721	1059		Marijuana and Patien t Protection Act is rescinded because the
722		-	individual or entity does not comply with the applicable
723		-	requirements set forth in this act the Oklahoma Medical Marijuana
724		-	and Patient Protection Act or rules promulgated pursuant thereto;
725		-	58. “School” means a public or private preschool or a public or
726		-	private elementary or secondary school used for school classes and
727	1060
728		-	SENATE FLOOR VERSION - SB680 SFLR Page 15
729		-	(Bold face denotes Committee Amendments) 1
	1061	+
	1062	+	Req. No. 1472 Page 15 1
	1063	+	2
	1064	+	3
	1065	+	4
	1066	+	5
	1067	+	6
	1068	+	7
	1069	+	8
	1070	+	9
	1071	+	10
	1072	+	11
	1073	+	12
	1074	+	13
	1075	+	14
	1076	+	15
	1077	+	16
	1078	+	17
	1079	+	18
	1080	+	19
	1081	+	20
	1082	+	21
	1083	+	22
	1084	+	23
	1085	+	24
	1086	+	1
730	1087		2
731	1088		3
732	1089		4
733	1090		5
734	1091		6
735	1092		7
736	1093		8
737	1094		9
738	1095		10
739	1096		11
740	1097		12
741	1098		13
742	1099		14
743	1100		15
744	1101		16
745	1102		17
746	1103		18
747	1104		19
748	1105		20
749	1106		21
750	1107		22
751	1108		23
752	1109		24
753	1110
	1111	+	individual or entity does not comply with the applicable
	1112	+	requirements set forth in this act the Oklahoma Medical Marijuana
	1113	+	and Patient Protection Act or rules promulgated pursuant thereto;
	1114	+	58. “School” means a public or private preschool or a public or
	1115	+	private elementary or secondary school used for school classes and
754	1116		instruction. A homeschool, daycare or child -care facility shall not
755	1117		be considered a “school” as used in this act the Oklahoma Medical
756	1118		Marijuana and Patient Protection Act ;
757	1119		59. “Shipping container” means a hard-sided container with a
758	1120		lid or other enclosure that can be secured in place. A shipping
759	1121		container is used solely for the transport of medical marijuana,
760	1122		medical marijuana concentrate, or medica l marijuana products between
761	1123		medical marijuana businesses, a medical mar ijuana research facility,
762	1124		or a medical marijuana education facility;
763	1125		60. “Solvent-based medical marijuana concentrate ” means a
764	1126		medical marijuana concentrate that was produced by extra cting
765	1127		cannabinoids from medical marijuana through the use of a solvent
766	1128		approved by the Department;
767	1129		61. “State Question” means Oklahoma State Question No . 788,
768	1130		Initiative Petition No. 412, approved by a ma jority vote of the
769	1131		citizens of Oklahoma on June 26, 2018;
770	1132		62. “Strain” means the classification of marijuana or cannabis
771	1133		plants in either pure sativa, indica, afgh anica, ruderalis or hybrid
772	1134		varieties;
773		-	63. “THC” means tetrahydrocannabinol, which is the pr imary
774		-	psychotropic cannabinoid in marijuana for med by decarboxylation of
775		-	naturally tetrahydrocannabinolic acid, which gener ally occurs by
776		-	exposure to heat;
777	1135
778		-	SENATE FLOOR VERSION - SB680 SFLR Page 16
779		-	(Bold face denotes Committee Amendments) 1
	1136	+
	1137	+	Req. No. 1472 Page 16 1
	1138	+	2
	1139	+	3
	1140	+	4
	1141	+	5
	1142	+	6
	1143	+	7
	1144	+	8
	1145	+	9
	1146	+	10
	1147	+	11
	1148	+	12
	1149	+	13
	1150	+	14
	1151	+	15
	1152	+	16
	1153	+	17
	1154	+	18
	1155	+	19
	1156	+	20
	1157	+	21
	1158	+	22
	1159	+	23
	1160	+	24
	1161	+	1
780	1162		2
781	1163		3
782	1164		4
783	1165		5
784	1166		6
785	1167		7
786	1168		8
787	1169		9
788	1170		10
789	1171		11
790	1172		12
791	1173		13
792	1174		14
793	1175		15
794	1176		16
795	1177		17
796	1178		18
797	1179		19
798	1180		20
799	1181		21
800	1182		22
801	1183		23
802	1184		24
803	1185
	1186	+	63. “THC” means tetrahydrocannabinol, which is the pr imary
	1187	+	psychotropic cannabinoid in marijuana formed by decarboxylation of
	1188	+	naturally tetrahydrocannabinolic acid, which gener ally occurs by
	1189	+	exposure to heat;
804	1190		64. “Test batch” means with regard to usable ma rijuana, a
805	1191		homogenous, identified quantity of usable marijuana by strain, no
806	1192		greater than ten (10) poun ds, that is harvested during a seven -day
807	1193		period from a specified cultiva tion area, and with regard to oils,
808	1194		vapors and waxes derived from usable marijuan a, means an identified
809	1195		quantity that is uniform, tha t is intended to meet specifications
810	1196		for identity, strength and composition, and that is manufactured,
811	1197		packaged and labeled during a specified time period according to a
812	1198		single manufacturing, packaging an d labeling protocol;
813	1199		65. “Transporter agent” means a person who transports medical
814	1200		marijuana or medical marijuana products for a licensed transporter
815	1201		and holds a transporter agent license pursuant to this act the
816	1202		Oklahoma Medical Marijuana and Patient Protection Act ;
817	1203		66. “Universal symbol” means the image established by the State
818	1204		Department of Health or O klahoma Medical Marijuana Authority and
819	1205		made available to licensees through its website indicating that the
820	1206		medical marijuana or t he medical marijuana product contains THC ;
821	1207		67. “Usable marijuana” means the dried leaves, flowers, oils,
822	1208		vapors, waxes and ot her portions of the marijuana plant and any
823		-	mixture or preparation thereof, excluding seed, roots, stems, stalks
824		-	and fan leaves; and
825		-	68. “Water-based medical marijuana co ncentrate” means a
826		-	concentrate that was produced by extracting cannabinoids from
827		-	medical marijuana through the use of only water, ice, or dry ice.
828	1209
829		-	SENATE FLOOR VERSION - SB680 SFLR Page 17
830		-	(Bold face denotes Committee Amendments) 1
	1210	+
	1211	+	Req. No. 1472 Page 17 1
	1212	+	2
	1213	+	3
	1214	+	4
	1215	+	5
	1216	+	6
	1217	+	7
	1218	+	8
	1219	+	9
	1220	+	10
	1221	+	11
	1222	+	12
	1223	+	13
	1224	+	14
	1225	+	15
	1226	+	16
	1227	+	17
	1228	+	18
	1229	+	19
	1230	+	20
	1231	+	21
	1232	+	22
	1233	+	23
	1234	+	24
	1235	+	1
831	1236		2
832	1237		3
833	1238		4
834	1239		5
835	1240		6
836	1241		7
837	1242		8
838	1243		9
839	1244		10
840	1245		11
841	1246		12
842	1247		13
843	1248		14
844	1249		15
845	1250		16
846	1251		17
847	1252		18
848	1253		19
849	1254		20
850	1255		21
851	1256		22
852	1257		23
853	1258		24
854	1259
	1260	+	mixture or preparation thereof, excluding seed, roots, stems, stalks
	1261	+	and fan leaves; and
	1262	+	68. “Water-based medical marijuana co ncentrate” means a
	1263	+	concentrate that was produced by extracting cannabinoids from
	1264	+	medical marijuana through the use of only water, ice, or dry ice.
855	1265		SECTION 2. AMENDATORY S ection 17, Chapter 11, O.S.L.
856	1266		2019, as amended by Section 4, Chapter 312, O.S.L. 2 019 (63 O.S.
857	1267		Supp. 2020, Section 427.17), is amended to read as follows:
858	1268		Section 427.17. A. There is hereby created a me dical marijuana
859	1269		testing laboratory license as a category of the medical marijuana
860	1270		business license. The Authority is hereby enabled to monitor,
861	1271		inspect and audit a licensed testing laboratory unde r this act
862	1272		Section 427.1 et seq. of th is title.
863	1273		B. The Authority is here by authorized to contr act with a
864	1274		private laboratory for the purpose of conducting compliance testing
865	1275		of medical marijuana testing la boratories licensed in this state.
866	1276		Any such laboratory under contract for compliance testing shall be
867	1277		prohibited from condu cting any other commer cial medical marijuana
868	1278		testing in this state.
869	1279		C. The Authority shall have the authority to develop acceptable
870	1280		testing and research practices , including but not limited to
871	1281		testing, standards, quality control analysis, equipment
872	1282		certification and calibratio n, and chemical identification and
873	1283		substances used in bona fide research methods so long as it complies
874		-	with this act the Oklahoma Medical Marijuana and Pati ent Protection
875		-	Act.
876		-	D. A person who is a direct beneficial owner or an indirect
877		-	beneficial owner of a medical marijuana dispensary, me dical
878	1284
879		-	SENATE FLOOR VERSION - SB680 SFLR Page 18
880		-	(Bold face denotes Committee Amendments) 1
	1285	+
	1286	+	Req. No. 1472 Page 18 1
	1287	+	2
	1288	+	3
	1289	+	4
	1290	+	5
	1291	+	6
	1292	+	7
	1293	+	8
	1294	+	9
	1295	+	10
	1296	+	11
	1297	+	12
	1298	+	13
	1299	+	14
	1300	+	15
	1301	+	16
	1302	+	17
	1303	+	18
	1304	+	19
	1305	+	20
	1306	+	21
	1307	+	22
	1308	+	23
	1309	+	24
	1310	+	1
881	1311		2
882	1312		3
883	1313		4
884	1314		5
885	1315		6
886	1316		7
887	1317		8
888	1318		9
889	1319		10
890	1320		11
891	1321		12
892	1322		13
893	1323		14
894	1324		15
895	1325		16
896	1326		17
897	1327		18
898	1328		19
899	1329		20
900	1330		21
901	1331		22
902	1332		23
903	1333		24
904	1334
	1335	+	with this act the Oklahoma Medical Marijuana and Patient Protection
	1336	+	Act.
	1337	+	D. A person who is a direct b eneficial owner or an indirect
	1338	+	beneficial owner of a medical marijuana dispensary, me dical
905	1339		marijuana commercial grower, or medical marijuana processor shall
906	1340		not be an owner of a laboratory.
907	1341		E. A laboratory and a laboratory applicant shall comply with
908	1342		all applicable local ordinances , including but not limited to
909	1343		zoning, occupancy, licensin g and building codes.
910	1344		F. A separate license shall be required for each sp ecific
911	1345		laboratory.
912	1346		G. A medical marijuana testing laboratory license may be issued
913	1347		to a person who performs testing and research on medical marijuana
914	1348		and, medical marijuana products and medical marijuana waste for
915	1349		medical marijuana busines ses, medical marijuana research facilities,
916	1350		medical marijuana educa tion facilities, and testing and research on
917	1351		medical marijuana and marijuana produc ts grown or produced by a
918	1352		patient or caregiver o n behalf of a patient, upon verification of
919	1353		registration. No stat e-approved medical marijuana testing facility
920	1354		shall operate unless a medical laboratory director is on site during
921	1355		operational hours.
922	1356		H. A laboratory applicant shall comply with the applica tion
923	1357		requirements of this section and shall submit such other info rmation
924	1358		as required for a medical marijuana business applic ant, in addition
925		-	to any information the Authority may request for initial approval
926		-	and periodic evaluations during the approval per iod.
927		-	I. A medical marijuana testing laboratory may accept samples of
928		-	medical marijuana, medical marijuana concentrate or, medical
929	1359
930		-	SENATE FLOOR VERSION - SB680 SFLR Page 19
931		-	(Bold face denotes Committee Amendments) 1
	1360	+
	1361	+	Req. No. 1472 Page 19 1
	1362	+	2
	1363	+	3
	1364	+	4
	1365	+	5
	1366	+	6
	1367	+	7
	1368	+	8
	1369	+	9
	1370	+	10
	1371	+	11
	1372	+	12
	1373	+	13
	1374	+	14
	1375	+	15
	1376	+	16
	1377	+	17
	1378	+	18
	1379	+	19
	1380	+	20
	1381	+	21
	1382	+	22
	1383	+	23
	1384	+	24
	1385	+	1
932	1386		2
933	1387		3
934	1388		4
935	1389		5
936	1390		6
937	1391		7
938	1392		8
939	1393		9
940	1394		10
941	1395		11
942	1396		12
943	1397		13
944	1398		14
945	1399		15
946	1400		16
947	1401		17
948	1402		18
949	1403		19
950	1404		20
951	1405		21
952	1406		22
953	1407		23
954	1408		24
955	1409
	1410	+	to any information the Authority may request for initial approval
	1411	+	and periodic evaluations during the approval per iod.
	1412	+	I. A medical marijuana testing laboratory may accept samples of
	1413	+	medical marijuana, medical marijuana concentrate or, medical
956	1414		marijuana product or medical marijuana waste from a medical
957	1415		marijuana business for testing and research p urposes only, which
958	1416		purposes may include t he provision of testing services for samples
959	1417		submitted by a medical marijuana business for product deve lopment.
960	1418		The Department may require a medical ma rijuana business to submit a
961	1419		sample of medical marijuana, medi cal marijuana concen trate or,
962	1420		medical marijuana product or medical marijuana waste to a medical
963	1421		marijuana testing laboratory upon demand.
964	1422		J. A medical marijuana testing laboratory may accept sa mples of
965	1423		medical marijuana, medical marijuana concentrate or medical
966	1424		marijuana product from an individual person for testing only under
967	1425		the following condit ions:
968	1426		1. The individual person is a patient or caregiver pursuant to
969	1427		this act the Oklahoma Medical Marijuana and Patient Protection Act
970	1428		or is a participant i n an approved clinical or observational study
971	1429		conducted by a research facility; an d
972	1430		2. The medical marijuana testing laboratory shall require
973	1431		requires the patient or caregiver to produce a valid patient license
974	1432		and current and valid photo identification.
975		-	K. A medical marijuana testing laboratory may transfer samples
976		-	to another medical marijuana testing laboratory for testing. All
977		-	laboratory reports provided to or by a medical marij uana business or
978		-	to a patient or caregiver shall identify the medical mari juana
979		-	testing laboratory that actually conducted the test.
980	1433
981		-	SENATE FLOOR VERSION - SB680 SFLR Page 20
982		-	(Bold face denotes Committee Amendments) 1
	1434	+
	1435	+	Req. No. 1472 Page 20 1
	1436	+	2
	1437	+	3
	1438	+	4
	1439	+	5
	1440	+	6
	1441	+	7
	1442	+	8
	1443	+	9
	1444	+	10
	1445	+	11
	1446	+	12
	1447	+	13
	1448	+	14
	1449	+	15
	1450	+	16
	1451	+	17
	1452	+	18
	1453	+	19
	1454	+	20
	1455	+	21
	1456	+	22
	1457	+	23
	1458	+	24
	1459	+	1
983	1460		2
984	1461		3
985	1462		4
986	1463		5
987	1464		6
988	1465		7
989	1466		8
990	1467		9
991	1468		10
992	1469		11
993	1470		12
994	1471		13
995	1472		14
996	1473		15
997	1474		16
998	1475		17
999	1476		18
1000	1477		19
1001	1478		20
1002	1479		21
1003	1480		22
1004	1481		23
1005	1482		24
1006	1483
	1484	+	K. A medical marijuana testing laboratory may transfer samples
	1485	+	to another medical marijuana testing laboratory for testing. All
	1486	+	laboratory reports provided to or by a medical marijuana business or
	1487	+	to a patient or caregiver shall identify the medical mari juana
	1488	+	testing laboratory that actually conducted the test.
1007	1489		L. A medical marijuana testing laboratory may utilize a
1008	1490		licensed medical marijuana transp orter to transport samples of
1009	1491		medical marijuana, medical marijua na concentrate and, medical
1010	1492		marijuana product and medical marijuana waste for testing, in
1011	1493		accordance with this act the Oklahoma Medical Marijuana and Patient
1012	1494		Protection Act and the rules adopted pursuant thereto, between the
1013	1495		originating medical marijuana business requesting testing services
1014	1496		and the destination laboratory performing testing s ervices.
1015	1497		M. The medical marijuana testing laboratory shall establish
1016	1498		policies to prevent the ex istence of or appearance of undue
1017	1499		commercial, financial or other influences that may diminish the
1018	1500		competency, impartiality and integrity of the testing processe s or
1019	1501		results of the laboratory, or that may diminish p ublic confidence in
1020	1502		the competency, impart iality and integrity of the testing processes
1021	1503		or results of the laboratory. At a minimum, employees, owners or
1022	1504		agents of a medical marijuana testing laboratory who participate in
1023	1505		any aspect of the analysis and res ults of a sample are prohibited
1024	1506		from improperly influencing the testing process, imprope rly
1025	1507		manipulating data, or improperly benefiting from any ongoing
1026		-	financial, employment, personal or business relat ionship with the
1027		-	medical marijuana business that provi ded the sample.
1028		-	N. The Department, pursua nt to rules promulgated by the State
1029		-	Commissioner of Health, shall develop standards, policies and
1030		-	procedures as necessary for:
1031	1508
1032		-	SENATE FLOOR VERSION - SB680 SFLR Page 21
1033		-	(Bold face denotes Committee Amendments) 1
	1509	+
	1510	+	Req. No. 1472 Page 21 1
	1511	+	2
	1512	+	3
	1513	+	4
	1514	+	5
	1515	+	6
	1516	+	7
	1517	+	8
	1518	+	9
	1519	+	10
	1520	+	11
	1521	+	12
	1522	+	13
	1523	+	14
	1524	+	15
	1525	+	16
	1526	+	17
	1527	+	18
	1528	+	19
	1529	+	20
	1530	+	21
	1531	+	22
	1532	+	23
	1533	+	24
	1534	+	1
1034	1535		2
1035	1536		3
1036	1537		4
1037	1538		5
1038	1539		6
1039	1540		7
1040	1541		8
1041	1542		9
1042	1543		10
1043	1544		11
1044	1545		12
1045	1546		13
1046	1547		14
1047	1548		15
1048	1549		16
1049	1550		17
1050	1551		18
1051	1552		19
1052	1553		20
1053	1554		21
1054	1555		22
1055	1556		23
1056	1557		24
1057	1558
	1559	+	financial, employment, personal or business relat ionship with the
	1560	+	medical marijuana business that provi ded the sample.
	1561	+	N. The Department, pursua nt to rules promulgated by the State
	1562	+	Commissioner of Health, shall develop standards, policies and
	1563	+	procedures as necessary for:
1058	1564		1. The cleanliness and orderlin ess of a laboratory premises and
1059	1565		the location of the l aboratory in a secure location, and inspec tion,
1060	1566		cleaning and maintenance of any equipmen t or utensils used for the
1061	1567		analysis of test samples;
1062	1568		2. Testing procedures, testing standards for cannabinoid and
1063	1569		terpenoid potency and safe levels of contaminants, an d remediation
1064	1570		procedures;
1065	1571		3. Controlled access areas for storage of medical marijuana a nd
1066	1572		medical marijuana product test samples, waste and reference
1067	1573		standards;
1068	1574		4. Records to be retained and computer systems to be utilized
1069	1575		by the laboratory;
1070	1576		5. The possession, storage and use by the laboratory of
1071	1577		reagents, solutions and reference standards ;
1072	1578		6. A certificate of analysis (COA) for each lot of reference
1073	1579		standard;
1074	1580		7. The transport and disposal of unused marijuana, marijuana
1075	1581		products and waste;
1076		-	8. The mandatory use by a laboratory of an inventory tracking
1077		-	system to ensure all test batches or samples containing medical
1078		-	marijuana, medical marijuana concentrate or, medical marijuana
1079		-	products or medical marijuana waste are identified and tracked from
1080		-	the point they are transferred from a medical mariju ana business, a
1081		-	patient or a caregiver thr ough the point of transfer, destruction or
1082	1582
1083		-	SENATE FLOOR VERSION - SB680 SFLR Page 22
1084		-	(Bold face denotes Committee Amendments) 1
	1583	+
	1584	+	Req. No. 1472 Page 22 1
	1585	+	2
	1586	+	3
	1587	+	4
	1588	+	5
	1589	+	6
	1590	+	7
	1591	+	8
	1592	+	9
	1593	+	10
	1594	+	11
	1595	+	12
	1596	+	13
	1597	+	14
	1598	+	15
	1599	+	16
	1600	+	17
	1601	+	18
	1602	+	19
	1603	+	20
	1604	+	21
	1605	+	22
	1606	+	23
	1607	+	24
	1608	+	1
1085	1609		2
1086	1610		3
1087	1611		4
1088	1612		5
1089	1613		6
1090	1614		7
1091	1615		8
1092	1616		9
1093	1617		10
1094	1618		11
1095	1619		12
1096	1620		13
1097	1621		14
1098	1622		15
1099	1623		16
1100	1624		17
1101	1625		18
1102	1626		19
1103	1627		20
1104	1628		21
1105	1629		22
1106	1630		23
1107	1631		24
1108	1632
	1633	+	8. The mandatory use by a laboratory of an inventory tracking
	1634	+	system to ensure all test batches or samples containing medical
	1635	+	marijuana, medical marijuana concentrate or, medical marijuana
	1636	+	products or medical marijuana waste are identified and tracked from
	1637	+	the point they are transferred from a medical mariju ana business, a
	1638	+	patient or a caregiver through the point of transfer, dest ruction or
1109	1639		disposal. The inventory tracking system reporting shall include the
1110	1640		results of any tests that are conducted on medical marijuana ,
1111	1641		medical marijuana concentrate or, medical marijuana product or
1112	1642		medical marijuana waste ;
1113	1643		9. Standards of performance;
1114	1644		10. The employment of l aboratory personnel;
1115	1645		11. A written standard operating procedure manual to be
1116	1646		maintained and updated by the labo ratory;
1117	1647		12. The successful participation in a Department-approved
1118	1648		proficiency testing program for each testing category listed in this
1119	1649		section, in order to obtain and maintain certification;
1120	1650		13. The establishment o f and adherence to a quality assurance
1121	1651		and quality control program to ensure suffi cient monitoring of
1122	1652		laboratory processes and quality of results reported;
1123	1653		14. The establishment by th e laboratory of a system to document
1124	1654		the complete chain of custody for s amples from receipt through
1125	1655		disposal;
1126		-	15. The establishment by the laboratory of a system to retain
1127		-	and maintain all required records, including business records, and
1128		-	processes to ensure results are reported in a timely and accurate
1129		-	manner; and
1130		-	16. Any other aspect of laboratory testing of med ical marijuana
1131		-	or, medical marijuana produ ct or medical marijuana waste deemed
1132		-	necessary by the Department.
1133	1656
1134		-	SENATE FLOOR VERSION - SB680 SFLR Page 23
1135		-	(Bold face denotes Committee Amendments) 1
	1657	+
	1658	+	Req. No. 1472 Page 23 1
	1659	+	2
	1660	+	3
	1661	+	4
	1662	+	5
	1663	+	6
	1664	+	7
	1665	+	8
	1666	+	9
	1667	+	10
	1668	+	11
	1669	+	12
	1670	+	13
	1671	+	14
	1672	+	15
	1673	+	16
	1674	+	17
	1675	+	18
	1676	+	19
	1677	+	20
	1678	+	21
	1679	+	22
	1680	+	23
	1681	+	24
	1682	+	1
1136	1683		2
1137	1684		3
1138	1685		4
1139	1686		5
1140	1687		6
1141	1688		7
1142	1689		8
1143	1690		9
1144	1691		10
1145	1692		11
1146	1693		12
1147	1694		13
1148	1695		14
1149	1696		15
1150	1697		16
1151	1698		17
1152	1699		18
1153	1700		19
1154	1701		20
1155	1702		21
1156	1703		22
1157	1704		23
1158	1705		24
1159	1706
	1707	+	15. The establishment by the laboratory of a system to retain
	1708	+	and maintain all required records , including business records, and
	1709	+	processes to ensure results are reported in a timely and accurate
	1710	+	manner; and
	1711	+	16. Any other aspect of laboratory testing of med ical marijuana
	1712	+	or, medical marijuana produ ct or medical marijuana waste deemed
	1713	+	necessary by the Department.
1160	1714		O. A medical marijuana testing laboratory shall promptly
1161	1715		provide the Department or designee of the Departme nt access to a
1162	1716		report of a test and any underlying data that is conduc ted on a
1163	1717		sample at the request of a medical marijuana business or qualified
1164	1718		patient. A medical marijuana testing laboratory shall also provid e
1165	1719		access to the Department or designee of th e Department to laboratory
1166	1720		premises and to any material or information requested by the
1167	1721		Department to determine compliance with the requirements of this
1168	1722		section.
1169	1723		P. A medical marijuana testing laboratory shall r etain all
1170	1724		results of laboratory tests conduc ted on medical marijuana or,
1171	1725		medical marijuana products or medical marijuana waste for a period
1172	1726		of at least two (2) years an d shall make them available to the
1173	1727		Department upon request.
1174	1728		Q. A medical marijuana testing laboratory shall test samples
1175	1729		from each harvest batch or product, production batch, as
1176	1730		appropriate, or waste batch of medical marijuana, medical marijuana
1177		-	concentrate and, medical marijuana product or medical marijuana
1178		-	waste for each of the following categories of testing, consistent
1179		-	with standards developed by the Commissioner:
1180		-	1. Microbials;
1181		-	2. Mycotoxins;
1182		-	3. Residual solvents;
1183		-	4. Pesticides;
1184	1731
1185		-	SENATE FLOOR VERSION - SB680 SFLR Page 24
1186		-	(Bold face denotes Committee Amendments) 1
	1732	+
	1733	+	Req. No. 1472 Page 24 1
	1734	+	2
	1735	+	3
	1736	+	4
	1737	+	5
	1738	+	6
	1739	+	7
	1740	+	8
	1741	+	9
	1742	+	10
	1743	+	11
	1744	+	12
	1745	+	13
	1746	+	14
	1747	+	15
	1748	+	16
	1749	+	17
	1750	+	18
	1751	+	19
	1752	+	20
	1753	+	21
	1754	+	22
	1755	+	23
	1756	+	24
	1757	+	1
1187	1758		2
1188	1759		3
1189	1760		4
1190	1761		5
1191	1762		6
1192	1763		7
1193	1764		8
1194	1765		9
1195	1766		10
1196	1767		11
1197	1768		12
1198	1769		13
1199	1770		14
1200	1771		15
1201	1772		16
1202	1773		17
1203	1774		18
1204	1775		19
1205	1776		20
1206	1777		21
1207	1778		22
1208	1779		23
1209	1780		24
1210	1781
	1782	+	concentrate and, medical marijuana pr oduct or medical marijuana
	1783	+	waste for each of the following categories of testing, consistent
	1784	+	with standards developed by the Commissioner:
	1785	+	1. Microbials;
	1786	+	2. Mycotoxins;
	1787	+	3. Residual solvents;
	1788	+	4. Pesticides;
1211	1789		5. Tetrahydrocannabinol (THC) and other cannabinoid potency;
1212	1790		6. Terpenoid potency; and
1213	1791		7. Heavy metals.
1214	1792		R. A test batch sha ll not exceed ten (10) pounds of usable
1215	1793		medical marijuana or, medical marijuana product , as appropriate or
1216	1794		medical marijuana waste. A grower shall separate each harvest lot
1217	1795		of usable marijuana into harvest batches containing no more than ten
1218	1796		(10) pounds. A processor shall sepa rate each medical marijuana
1219	1797		production lot into production batches containing no m ore than ten
1220	1798		(10) pounds. A grower or processor shall separate each medical
1221	1799		marijuana waste lot into waste batches containing no more than ten
1222	1800		(10) pounds.
1223	1801		S. Medical marijuana testing laboratory licensure shall be
1224	1802		contingent upon successful on -site inspection, successful
1225	1803		participation in proficiency testing and on going compliance with the
1226	1804		applicable requirements in this section.
1227		-	T. A medical marijua na testing laboratory sh all be inspected
1228		-	prior to initial licens ure and annually thereafter by an inspecto r
1229		-	approved by the Authority.
1230		-	U. Beginning on a date determined by the Commissioner, not
1231		-	later than January 1, 2020, medical marijuana testing laborat ory
1232		-	licensure shall be c ontingent upon accreditation by the NELA C
1233		-	Institute (TNI), ANSI/ASQ National Accre ditation Board or another
1234	1805
1235		-	SENATE FLOOR VERSION - SB680 SFLR Page 25
1236		-	(Bold face denotes Committee Amendments) 1
	1806	+
	1807	+	Req. No. 1472 Page 25 1
	1808	+	2
	1809	+	3
	1810	+	4
	1811	+	5
	1812	+	6
	1813	+	7
	1814	+	8
	1815	+	9
	1816	+	10
	1817	+	11
	1818	+	12
	1819	+	13
	1820	+	14
	1821	+	15
	1822	+	16
	1823	+	17
	1824	+	18
	1825	+	19
	1826	+	20
	1827	+	21
	1828	+	22
	1829	+	23
	1830	+	24
	1831	+	1
1237	1832		2
1238	1833		3
1239	1834		4
1240	1835		5
1241	1836		6
1242	1837		7
1243	1838		8
1244	1839		9
1245	1840		10
1246	1841		11
1247	1842		12
1248	1843		13
1249	1844		14
1250	1845		15
1251	1846		16
1252	1847		17
1253	1848		18
1254	1849		19
1255	1850		20
1256	1851		21
1257	1852		22
1258	1853		23
1259	1854		24
1260	1855
	1856	+	T. A medical marijua na testing laboratory sh all be inspected
	1857	+	prior to initial licens ure and annually thereafter by an inspecto r
	1858	+	approved by the Authority.
	1859	+	U. Beginning on a date determine d by the Commissioner, not
	1860	+	later than January 1, 2020, medical marijuana testing laborat ory
	1861	+	licensure shall be c ontingent upon accreditation by the NELA C
	1862	+	Institute (TNI), ANSI/ASQ National Accre ditation Board or another
1261	1863		accrediting body approved by the Com missioner, and any applicable
1262	1864		standards as determined by the Department.
1263	1865		V. 1. A commercial grower shall not t ransfer or sell medical
1264	1866		marijuana and a processor shall not transfer, sell or proc ess into a
1265	1867		concentrate or product any medical marijuana, medical m arijuana
1266	1868		concentrate or medical marijuana product unless samples from each
1267	1869		harvest batch or production batch from which that medical marijuana ,
1268	1870		medical marijuana concentrate or medical marij uana product was
1269	1871		derived has have been tested by a medical marijuana te sting facility
1270	1872		for contaminants and passed all contaminant tests required by this
1271	1873		act the Oklahoma Medical Marijuana and Patient Protection Act .
1272	1874		2. A processor shall not transfer, sell or proce ss into a
1273	1875		concentrate or product any medical mari juana, medical marijua na
1274	1876		concentrate or medical marijuana product unless samples from each
1275	1877		production batch from which that medical marijuana, medical
1276	1878		marijuana concentrate or medical marijuana product was derived have
1277		-	been tested by a medi cal marijuana testing facility for con taminants
1278		-	and passed all contaminant tests required by this act.
1279		-	3. A commercial grower or process or shall not transfer medical
1280		-	marijuana waste to a medical marijuana waste disposa l facility
1281		-	unless samples from each waste batch from which that medical
1282		-	marijuana waste was derived have been tested by a medical marijuana
1283		-	testing facility for contaminants .
1284	1879
1285	1880
1286		-	SENATE FLOOR VERSION - SB680 SFLR Page 26
1287		-	(Bold face denotes Committee Amendments) 1
	1881	+	Req. No. 1472 Page 26 1
	1882	+	2
	1883	+	3
	1884	+	4
	1885	+	5
	1886	+	6
	1887	+	7
	1888	+	8
	1889	+	9
	1890	+	10
	1891	+	11
	1892	+	12
	1893	+	13
	1894	+	14
	1895	+	15
	1896	+	16
	1897	+	17
	1898	+	18
	1899	+	19
	1900	+	20
	1901	+	21
	1902	+	22
	1903	+	23
	1904	+	24
	1905	+	1
1288	1906		2
1289	1907		3
1290	1908		4
1291	1909		5
1292	1910		6
1293	1911		7
1294	1912		8
1295	1913		9
1296	1914		10
1297	1915		11
1298	1916		12
1299	1917		13
1300	1918		14
1301	1919		15
1302	1920		16
1303	1921		17
1304	1922		18
1305	1923		19
1306	1924		20
1307	1925		21
1308	1926		22
1309	1927		23
1310	1928		24
1311	1929
	1930	+	been tested by a medical marijuana te sting facility for con taminants
	1931	+	and passed all contaminant tests required by this act.
	1932	+	3. A commercial grower or process or shall not transfer medical
	1933	+	marijuana waste to a medical marijuana waste disposal fa cility
	1934	+	unless samples from each waste batch from which that medical
	1935	+	marijuana waste was derived have been tested by a medical marijuana
	1936	+	testing facility for contaminants .
1312	1937		SECTION 3. This act shall become effective November 1, 2021.
1313		-	~~COMMITTEE REPORT BY: COMMITTEE ON HEALT H AND HUMAN SERVICES~~
1314		-	~~February 22,~~ 2021 ~~- DO PASS~~
	1938	+
	1939	+	58-1-1472 DC 1/21/2021 11:49:25 AM